noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

City of Broken Arrow, OK

Broken Arrow in Motion January 2026
The University of Texas at Austin

New Findings Reshape How Scientists Understand Microscopic Behavior of[...]
Paramount Gold Nevada Corp.

Statement of Changes in Beneficial Ownership (Form 4)

Healthcare

AHA - American Hospital Association

01/28/2026 | News release | Distributed by Public on 01/28/2026 15:09

CMS announces drugs selected for third round of drug price negotiations

The Centers for Medicare & Medicaid Services yesterday announced 15 drugs under Medicare Parts D and B selected for the third round of price negotiations. Negotiations will occur this year and any resulting prices will become effective in 2028. CMS said the selected drugs accounted for nearly $27 billion, or nearly 6%, in total prescription drug spending under Parts D and B between November 2024 and October 2025. Additionally, CMS released a list of the top 50 negotiation-eligible drugs based on combined expenditures under Parts D and B.

Drug Prices

Drug Price Transparency

AHA - American Hospital Association published this content on January 28, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on January 28, 2026 at 21:10 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]

Back

View original format